Jenifer Wogen

949 total citations
28 papers, 714 citations indexed

About

Jenifer Wogen is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jenifer Wogen has authored 28 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Public Health, Environmental and Occupational Health and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jenifer Wogen's work include Blood Pressure and Hypertension Studies (9 papers), Health Promotion and Cardiovascular Prevention (4 papers) and Diabetes Management and Research (4 papers). Jenifer Wogen is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Health Promotion and Cardiovascular Prevention (4 papers) and Diabetes Management and Research (4 papers). Jenifer Wogen collaborates with scholars based in United States, Switzerland and Japan. Jenifer Wogen's co-authors include Stephen J. Boccuzzi, Daniel Belletti, James M. Fox, Jennifer Sung, Jennifer Kim, Craig Plauschinat, Aylin Riedel, Herbert C. Heien, Nancy C. Santanello and Peg Strub and has published in prestigious journals such as Gastroenterology, Diabetes Care and Cancer Research.

In The Last Decade

Jenifer Wogen

26 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jenifer Wogen United States	12	291	137	121	115	102	28	714
Helen Lau United States	13	179 0.6×	129 0.9×	55 0.5×	80 0.7×	57 0.6×	23	610
Joanna Huang United States	17	247 0.8×	332 2.4×	85 0.7×	92 0.8×	112 1.1×	37	859
Lucas Van Bortel Belgium	14	116 0.4×	159 1.2×	177 1.5×	108 0.9×	178 1.7×	33	768
Olga Archangelidi United Kingdom	9	320 1.1×	59 0.4×	86 0.7×	28 0.2×	67 0.7×	14	741
Daniala L. Weir Canada	12	315 1.1×	210 1.5×	27 0.2×	69 0.6×	40 0.4×	31	714
Craig Plauschinat United States	18	455 1.6×	310 2.3×	234 1.9×	384 3.3×	330 3.2×	29	1.3k
Jochen Schuler Austria	9	136 0.5×	271 2.0×	101 0.8×	62 0.5×	28 0.3×	10	691
Hieronymus J. Derijks Netherlands	14	173 0.6×	68 0.5×	46 0.4×	29 0.3×	87 0.9×	47	699
Jens Bos Netherlands	18	98 0.3×	107 0.8×	45 0.4×	43 0.4×	39 0.4×	74	834
Bruce M. Psaty United States	10	215 0.7×	562 4.1×	76 0.6×	36 0.3×	61 0.6×	12	961

Countries citing papers authored by Jenifer Wogen

Since Specialization

Citations

This map shows the geographic impact of Jenifer Wogen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenifer Wogen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenifer Wogen more than expected).

Fields of papers citing papers by Jenifer Wogen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenifer Wogen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenifer Wogen. The network helps show where Jenifer Wogen may publish in the future.

Co-authorship network of co-authors of Jenifer Wogen

This figure shows the co-authorship network connecting the top 25 collaborators of Jenifer Wogen. A scholar is included among the top collaborators of Jenifer Wogen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenifer Wogen. Jenifer Wogen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Masri, Ahmad, Yong Chen, Aaron Crowley, et al.. (2025). Coexisting Calcific Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Real‐World Evaluation of Clinical Characteristics and Outcomes. Journal of the American Heart Association. 14(2). e033251–e033251. 2 indexed citations

Kato, Takao, Denis Keohane, José Alvir, et al.. (2024). Tafamidis Medication Adherence and Persistence in Patients with Transthyretin Amyloid Cardiomyopathy in Japan. ESC Heart Failure. 11(5). 2881–2888. 2 indexed citations

Miller, Bradley S., Jane Loftus, Craig S. Parzynski, et al.. (2024). Impact of Daily Growth Hormone Adherence on Height Velocity Among Children With Growth Hormone Deficiency (GHD). Endocrine Practice. 30(9). 837–846.

O’Shaughnessy, Joyce, Denise A. Yardley, Lowell L. Hart, et al.. (2023). Abstract P3-03-12: Risk of recurrence with adjuvant endocrine therapy in real world patients with hormone receptor positive/human epidermal growth factor receptor-negative early breast cancer: a US database analysis. Cancer Research. 83(5_Supplement). P3–3. 2 indexed citations

Spector, Antoinette L., et al.. (2022). Mechanisms for Expanding Harm Reduction for Opioid Use in Suburban and Rural U.S. Settings. Journal of Drug Issues. 53(2). 196–212. 8 indexed citations

Wong, Ken, et al.. (2013). Impact of care management processes and integration of care on blood pressure control in diabetes. BMC Family Practice. 14(1). 30–30. 6 indexed citations

Mallick, Rajiv, Jennifer Cai, & Jenifer Wogen. (2013). Predictors of non-adherence to systemic oral therapy for advanced hepatocellular carcinoma. Current Medical Research and Opinion. 29(12). 1701–1708. 10 indexed citations

Wong, Ken, et al.. (2011). The association between hypertension-specific care management processes and blood pressure outcomes in US-based physician organizations. Journal of the American Society of Hypertension. 5(6). 505–512. 8 indexed citations

Belletti, Daniel, Christopher Zacker, & Jenifer Wogen. (2010). Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States. Cardiovascular Diabetology. 9(1). 7–7. 25 indexed citations

10.

Belletti, Daniel, Christopher Zacker, & Jenifer Wogen. (2010). Hypertension Treatment and Control Among 28 Physician Practices Across the United States: Results of the Hypertension: Assessment of Treatment to Target (HATT) Study. Journal of Clinical Hypertension. 12(8). 603–612. 4 indexed citations

11.

Belletti, Daniel, et al.. (2008). Identifying Barriers to Hypertension Care: Implications for Quality Improvement Initiatives. Disease Management. 11(2). 71–77. 38 indexed citations

12.

Frech‐Tamas, Feride, et al.. (2008). Blood Pressure Control Among Diabetes Patients Within a Managed Care Setting. American Journal of Medical Quality. 23(3). 201–207.

13.

Riedel, Aylin, Herbert C. Heien, Jenifer Wogen, & Craig Plauschinat. (2007). Loss of Glycemic Control in Patients with Type 2 Diabetes Mellitus Who Were Receiving Initial Metformin, Sulfonylurea, or Thiazolidinedione Monotherapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(8). 1102–1110. 71 indexed citations

14.

Wittkowsky, Ann K., Stephen J. Boccuzzi, Jenifer Wogen, et al.. (2004). Frequency of Concurrent Use of Warfarin with Potentially Interacting Drugs. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(12). 1668–1674. 60 indexed citations

15.

Tardif, Jean‐Claude, Anique Ducharme, Holly Yu, Jenifer Wogen, & Marie‐Claude Guertin. (2004). Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension. Clinical Therapeutics. 26(7). 1073–1083. 2 indexed citations

16.

Jones, Craig, et al.. (2003). Adherence to Prescribed Treatment for Asthma: Evidence from Pharmacy Benefits Data. Journal of Asthma. 40(1). 93–101. 107 indexed citations

17.

Laine, Loren, Jenifer Wogen, & Holly Yu. (2003). Gastrointestinal health care resource utilization with chronic use of COX-2-specific inhibitors versus traditional NSAIDs1 1The Institute for Effectiveness Research, LLC, is a subsidiary of Medco Health Solutions, Inc., a Merck Company.. Gastroenterology. 125(2). 389–395. 27 indexed citations

18.

Blonde, Lawrence, Jenifer Wogen, C. Kreilick, & Andrea A. Seymour. (2003). Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co‐administered with metformin. Diabetes Obesity and Metabolism. 5(6). 424–431. 67 indexed citations

19.

Laine, Loren, Jenifer Wogen, & Stephen J. Boccuzzi. (2002). Do coxibs decrease GI health care resource utilization as compared to traditional NSAIDs. 1. 53. 1 indexed citations

20.

Boccuzzi, Stephen J., et al.. (2000). Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications. Clinical Therapeutics. 22(2). 237–247. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact